US20220047797A1 - Expandable fluid collection canister - Google Patents

Abstract

A bodily fluid collection system includes a reduced pressure treatment unit for providing reduced pressure to a fluid collection system through a canister having a container with an inlet adapted to be fluidly coupled to the fluid collection system, an outlet adapted to be connected to a source of reduced pressure, and an absorptive lamination disposed within the container. The absorptive lamination may be formed from a plurality of absorptive layers and wicking layers interleaved between the absorptive layers that collectively manifold bodily fluids from a tissue site into and throughout the absorptive lamination to trap and collect the bodily fluids. The container expands as the absorptive lamination swells with the bodily fluid being collected.

Description

• The present application is a Continuation of U.S. patent application Ser. No. 16/107,835, entitled “EXPANDABLE FLUID COLLECTION CANISTER,” filed Aug. 21, 2018, which is a Divisional of U.S. patent application Ser. No. 14/162,432, entitled “EXPANDABLE FLUID COLLECTION CANISTER,” filed Jan. 23, 2014, now U.S. Pat. No. 10,092,682, which claims the benefit, under 35 USC § 119(e), of U.S. Provisional Patent Application No. 61/780,143, entitled “EXPANDABLE FLUID COLLECTION CANISTER,” filed Mar. 13, 2013, which are incorporated herein by reference for all purposes.
TECHNICAL FIELD
• The present invention relates generally to tissue treatment systems and in particular to systems and methods for collecting bodily fluid.
BACKGROUND
• Clinical studies and practice have shown that providing a reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, including faster healing and increased formulation of granulation tissue. Typically, reduced pressure is applied to tissue through a porous pad or other manifold device. The porous pad contains cells or pores that are capable of distributing reduced pressure to the tissue and channeling fluids that are drawn from the tissue. The porous pad often is incorporated into a dressing having other components that facilitate treatment.
• Wound fluids or exudates are generally collected in a canister for disposal or analysis. Wound fluid primarily comprises plasma in addition to red and white blood cells, platelets, bacteria, and a variety of proteinaceous material. Plasma consists primarily of saline. In clinical practice, canisters should be sized appropriately to obviate the need for frequent replacement even when used in the treatment of patients with wounds generating a high volume of exudate. Conversely, canisters should not be bulky so as to fill care facilities' storage spaces or consume unnecessary resources for hazardous waste disposal of canisters filled with potentially infectious bodily fluid.
SUMMARY
• In one illustrative embodiment, a bodily fluid canister comprises an inlet, an outlet, a container, and a plurality of layers of absorptive material and a plurality of layers of wicking material contained within the container. The plurality of layers of wicking material may be situated proximate to the plurality of layers of absorptive material. The plurality of layers of wicking material may be oriented in an alternating pattern with the plurality of layers of absorptive material such that each layer of absorptive material is proximate to at least one layer of manifold material. The plurality of layers of wicking material and the plurality of layers of absorptive material may be oriented essentially vertically with the container.
• In another illustrative embodiment, a bodily fluid canister is provided for use with a reduced pressure treatment system. The bodily fluid canister comprises an inlet, an outlet, liquid impervious container, and a plurality of layers of absorptive material and a plurality of layers of wicking material contained within the container. The inlet may be disposed in the container, the inlet adapted to be fluidly connected to a tissue site. The reduced pressure treatment system may include a porous pad positioned proximate to a tissue site. An outlet may be disposed in the container and is adapted to be fluidly connected to a reduced pressure source. A plurality of layers of wicking material and a plurality of layers of absorptive material may be positioned within the container. The plurality of layers of wicking material and the plurality of layers of absorptive material may be positioned proximate to one another and each of the plurality of layers of absorptive material may be positioned proximate to at least one of the plurality of layers of manifold material. The plurality of layer of wicking material and the plurality of layers of absorptive material may be oriented essentially vertically within the container. The container may be configured to be volumetrically expandable.
• In still another embodiment, a method for volumetrically expanding a bodily fluid canister is provided. The method comprises introducing bodily fluid into a canister, the canister comprising a container containing a plurality of layers of absorptive material within the canister adapted to attract and retain bodily fluid and a plurality of layers of wicking material within the canister adapted to distribute bodily fluid along the plurality of layers of absorptive material. The method further comprises volumetrically expanding the canister, the canister configured to expand upon bodily fluid distribution to the plurality of layers of wicking material and the plurality of layers of absorptive material.
• In yet another embodiment, a canister for collecting bodily fluids from a fluid collection system for delivering reduced pressure to a tissue site from a source of reduced pressure is disclosed. The canister may comprise a container having a chamber being expandable to receive and collect bodily fluids from the tissue site in response to the application of the reduced pressure, an inlet fluidly coupled to the chamber of the container and configured to be in fluid communication with the fluid collection system for delivering the bodily fluids into the chamber of the container, and an outlet fluidly coupled to the chamber of the container and configured to be in fluid communication with the source of reduced pressure for providing reduced pressure through the chamber of the container to the fluid collection system. The canister may further comprise an absorptive lamination disposed within the container and adapted to trap and collect a liquid portion of the bodily fluids separated from the gaseous portion of the bodily fluids flowing from the inlet to the outlet within the container, wherein the container expands as the absorptive lamination swells to absorb the liquid portion of the bodily fluids. The absorptive lamination may comprise a plurality of absorptive layers and a plurality of wicking layers interleaved between the absorptive layers.
• Other objects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 shows a perspective view of a bodily fluid collection system comprising a reduced pressure treatment unit for providing reduced pressure to a fluid collection system through a first embodiment of a canister including a container having absorptive layers with interleaving wicking layers disposed in the container according to an illustrative embodiment;
• FIG. 2 shows an exploded, cross-sectional view of the canister and a partially schematic cross-sectional view of the reduced pressure treatment unit comprising components of the bodily fluid collection system ofFIG. 1;
• FIG. 2A shows the canister ofFIG. 2 with the container partially filled with bodily fluids drawn from the fluid collection system;
• FIG. 2B shows the canister ofFIG. 2 with the container completely filled with bodily fluids drawn from the fluid collection system; and
• FIG. 3 shows a perspective view of a second embodiment of a container for collecting bodily fluids in the bodily fluid collection system ofFIG. 1.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
• In the following detailed description of several illustrative embodiments, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration specific preferred embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
• The term “reduced pressure” as used herein generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure reduction applied to the tissue site may be significantly less than the pressure reduction normally associated with a complete vacuum. Reduced pressure may initially generate fluid flow in the area of the tissue site. As the hydrostatic pressure around the tissue site approaches the desired reduced pressure, the flow may subside, and the reduced pressure is then maintained. Unless otherwise indicated, values of pressure stated herein are gauge pressures. Similarly, references to increases in reduced pressure typically refer to a decrease in absolute pressure, while decreases in reduced pressure typically refer to an increase in absolute pressure.
• The term “tissue site” as used herein refers to a wound or defect located on or within any tissue, including but not limited to, bone tissue, adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, or ligaments. The term “tissue site” may further refer to areas of any tissue that are not necessarily wounded or defective, but are instead areas in which it is desired to add or promote the growth of additional tissue. For example, reduced pressure tissue treatment may be used in certain tissue areas to grow additional tissue that may be harvested and transplanted to another tissue location.
• Referring toFIGS. 1 and 2, a reducedpressure treatment system10 comprises afluid collection system100 for applying reduced pressure therapy to a patient, a reducedpressure treatment unit101 for providing the reduced pressure, and acanister102 fluidly coupled between thefluid collection system100 and the reducedpressure treatment unit101 for collecting fluids from a patient according to one illustrative embodiment. Thecanister102 comprises acontainer103 having a chamber, aninlet104 being a coupling for providing fluid communication into the chamber of thecontainer103, and anoutlet105 being a coupling for providing fluid communication out from the chamber of thecontainer103. Theinlet104 is adapted to be fluidly coupled to thefluid collection system100 for providing reduced pressure to thefluid collection system100 and receiving bodily fluids from the patient. Theoutlet105 is adapted to be connected to a reducedpressure port107 of the reducedpressure treatment unit101 to provide reduced pressure to thefluid collection system100 from a reducedpressure source108 that may be contained within the reducedpressure treatment unit101. Theinlet104 and theoutlet105 are preferably disposed at one end of thecontainer103 so that both may be positioned at a higher elevation relative to the other end of thecontainer103 when thecanister102 is utilized in operation. Thecanister102 may further comprise a support member such as, for example, acarrier ring109 that may be releasably connected to the reducedpressure treatment unit101 to hold thecontainer103 in place during operation of the reducedpressure treatment unit101.
• Thefluid collection system100 is adapted to be positioned proximate atissue site110 of a patient for delivering reduced pressure to thetissue site110 and collecting bodily fluids from thetissue site110. Thefluid collection system100 comprises a manifold112 in fluid communication with thetissue site110 and adrape114 adapted to cover the manifold112 for providing a substantially airtight seal over thetissue site110. Thefluid collection system100 may further comprise aconnector116 fluidly coupled to the manifold112 through thedrape114 and a conduit ortube118 containing at least one lumen for the transmission of fluids, both gaseous and liquid. Thetube118 is adapted to be fluidly coupled between theconnector116 and theinlet104 of thecanister102 for transmitting fluids between thecanister102 and thetissue site110.
• The manifold112 may be a bioabsorbable or bioinert material capable of distributing reduced pressure at various desired levels. Thedrape114 may include an adhesive seal (not shown) that not only maintains the reduced pressure at various levels, but also holds thefluid collection system100 in place over thetissue site110. The manifold112 may be a bioabsorbable or bioinert material capable of distributing reduced pressure to thetissue site110. In one embodiment, the manifold112 may be an open cell, reticulated foam comprising, for example, a polyurethane material. The wound dressing112 delivers reduced pressure to thetissue site110 to provide therapeutic treatment to thetissue site110 and allows exudates and bodily fluids to flow from thetissue site110 to thecanister102 where the exudates and bodily fluids are collected.
• The reducedpressure treatment unit101 may comprise the reducedpressure source108 as described above. The reducedpressure source108 may be, for example, a vacuum pump driven by a motor. In another embodiment, reduced pressure may be provided by a manually-actuated pump such as a compressible bellows pump. In still another embodiment, the reduced pressure may be provided by a wall suction port either with or without a separate pressure regulator. The reducedpressure treatment unit101 may also comprise a processing unit (not shown) for controlling various features of the reducedpressure treatment unit101 such as, for example, the level and timing of the reduced pressure being applied to thetissue site110. The reducedpressure treatment unit101 may further comprise other equipment such as, for example, a source of positive pressure.
• Thecontainer103 may be constructed of a liquid impervious material such as, for example, a thermoplastic material such as polyurethane to contain the exudates and bodily fluids collected from thetissue site110. The chamber of thecontainer103 may have a volume that is preferably variable to accommodate the collection of exudates and bodily fluids from thetissue site110 expanding from an empty state to a full state after collecting such fluids. In one embodiment, thecontainer103 may comprise a flexible bag having walls that are elastic and expandable as needed to accommodate the collection of exudates and bodily fluids. In another embodiment, the flexible bag may have walls that are less elastic or inelastic but nonetheless collapsible in the empty state and expandable to the full state as needed to accommodate the collection of exudates and bodily fluids. In one embodiment, thecontainer103 may comprise a flexible bag formed from a single tubular sheet of film sealed at both ends. In another embodiment, thecontainer103 may comprise a flexible bag formed from two sheets of film sealed around the edges and shown more specifically inFIG. 1 which shows the chamber having an oval shape. The chamber of thecontainer103 may have a circular or rectangular shape (e.g., see the chamber ofcontainer303 inFIG. 3) as necessary to accommodate the structure and fluidics of the system.
• In yet another embodiment, thecontainer103 may comprise two walls joined around the edges by a connecting member that provides expandability of the chamber of thecontainer103. Referring more specifically toFIG. 2, thecontainer103 may comprise afirst wall120, asecond wall122, and a connectingmember124, wherein the perimeters of thefirst wall120 and thesecond wall122 are joined together by the connectingmember124. Thefirst wall120, thesecond wall122, and the connectingmember124 define the chamber of thecontainer103 that may accommodate the exudates and bodily fluids as they are collected from thetissue site110. In one embodiment, the connectingmember124 may comprise one or more pleats126 that allow the chamber of thecontainer103 to expand from the empty state to the filled state. In another embodiment, the connectingmember124 may comprise a material with elastic characteristics. In yet another embodiment, the connectingmember124 may be configured as a Z-fold to permit expansion of the chamber of thecontainer103. Other configurations of thecontainer103 may provide similar volumetric expandability of the chamber.
• As indicated above, theinlet104 and theoutlet105 are preferably disposed at one end of thecontainer103 so that both may be positioned at a higher elevation relative to the other end of thecontainer103 when thecanister102 is utilized in operation. Thus, thecontainer103 may be oriented more vertically with theinlet104 and theoutlet105 being elevated to utilize gravity to facilitate filling the chamber of thecontainer103 with the exudates and bodily fluids being collected. In one embodiment, thecontainer103 may contain an absorptive material such as a foam, hydrogel, or a water-swelling polymer for collecting and treating the exudates and bodily fluids being collected from thetissue site110. In such embodiments, it is also desirable that the exudates and bodily fluids enter the chamber of thecontainer103 on the distal side of thecontainer103 adjacent thefirst wall120 allowing the absorptive material to trap and collect the liquid fluids while the gaseous fluids exit the chamber of thecontainer103 on the proximal side of thecontainer103 adjacent thesecond wall122. Thus, theinlet104 and theoutlet105 may be disposed on opposing walls of thecontainer103. In another embodiment as more specifically shown in the figures, theinlet104 and theoutlet105 may both be disposed on the proximal side of thecontainer103 through thesecond wall122 wherein theinlet104 is in fluid communication with atube127 having adistal end128 extending within the chamber to the distal side of thecontainer103 adjacent thefirst wall120 so that the absorptive material better traps and collects the liquid fluids while the gaseous fluids exit the chamber of thecontainer103 through theoutlet105 as illustrated byarrows129 representing the flow of the fluids.
• When thecontainer103 is filled with an absorptive material in bulk volume, the absorbent material often failed to expand or inflate thecontainer103 to completely fill the chamber of thecontainer103 with the exudates and bodily fluids being collected from thetissue site110. Moreover, the absorptive material tended to saturate in localized areas without absorbing the fluids throughout the entire volume of the absorptive material. Even when thecontainer103 and the absorptive material within thecontainer103 were oriented vertically, the vertical orientation exacerbated the localized saturation condition. It is desirable to overcome these problems so that thecontainer103 would be completely filled to reduce the expense associated with utilizing additional containers and reduce the maintenance required by the patient or a caregiver.
• These problems are overcome by disposing individual layers of absorptive material within thecontainer103 wherein the absorptive layers are spaced apart from one another that may form an absorptive lamination to enhance the collection and flow of fluids throughout the entire volume of the absorptive lamination. These problems are further overcome by interleaving layers of wicking material within the space between the absorptive layers to further enhance the flow of fluids between the absorptive layers and throughout the entire volume of the absorptive lamination. Using such an absorptive lamination including wicking layers interleaved between the absorptive layers within thecontainer103 greatly enhances the ability of thecontainer103 to expand and completely fill to overcome these problems and do so regardless of orientation. When thecontainer103 contains an absorptive lamination as just described, the absorptive capabilities of thecontainer103 are still enhanced when the container is oriented in a horizontal position as opposed to a vertical position.
• Referring more specifically toFIG. 2, one exemplary embodiment of anabsorptive lamination130 is shown and comprises a plurality ofabsorptive layers132 of absorptive material that are spaced apart from each other as described above. Theabsorptive layers132 may be spaced apart from each other by spacers (not shown) or any other means to maintain the spaced apart relationship between theabsorptive layers132 when subjected to a reduced pressure during operation of the reducedpressure treatment unit101. Theabsorptive lamination130 contains a plurality of wickinglayers134 of wicking material disposed between theabsorptive layers132. In one embodiment, onewicking layer134 may be disposed or interleaved between eachabsorptive layer132 as described above but not shown. In another embodiment, onewicking layer134 may be disposed proximate each side of one of theabsorptive layers132 such that a pair of wickinglayers134 may be associated with eachabsorptive layer132 as shown. In this embodiment, theabsorptive lamination130 may further comprisespacers135 disposed between each pair of wickinglayers134 to provide further spacing between theabsorptive layers132. Theabsorptive lamination130 may be oriented within the chamber of thecontainer103 so that theabsorptive layers132 and the wicking layers134 are substantially parallel to thefirst wall120 and thesecond wall122 of thecontainer103. These embodiments enhance the distribution of bodily fluids to theabsorptive layers132 throughout the entire chamber of thecontainer103 to enhance the fluid storage capability of theabsorptive lamination130.
• The wicking layers134 may comprise a wicking material having flow channels that support the flow of fluids at least through the width of eachwicking layer134, i.e., generally perpendicular to the length or longitudinal axis of thewicking layer134. The flow channels of the wicking material are capable of supporting the flow of fluids even when under reduced pressure being applied within thecontainer103. The wicking material may be a non-woven material such as, for example, Libeltex TDL2 available from LIBELTEX bvba located in Belgium, or a reticulated open-cell polyurethane foam. Theabsorptive layers132 may comprise, for example, a textile substrate (e.g., woven or knit fabrics), a foam, a hydrogel, a hydrocolloid, a superabsorbent polymer (e.g., Texsus CCBSL 130LL available from Texsus Spa located in Italy), a silica gel, a water swelling polymer, a polysaccharide (e.g., chitosan, carboxymethylcellulose, hydroxylmethylcellulose, hyaluronic acid, alginate, pectin, etc.), a proteinaceous material (glycoprotein, gelatin, etc.), and combinations thereof.
• The wicking layers134 and theabsorptive layers132 of may each further comprise an antimicrobial agent and thus be adapted to have antimicrobial properties to effect a bioburden log reduction of greater than one or, more preferably, greater than three. By way of a non-limiting example, this antimicrobial property may be accomplished by adding ionic silver to the wicking material of the wicking layers134 or the absorptive material of the absorptive layers132. The wicking layers134 and theabsorptive layers132 of may each further comprise other chemicals or agents to facilitate the collection and storage of exudates and bodily fluids from thetissue site110.
• Thecanister102 may further comprise a firsttextured layer136 contained within thecontainer103 adjacent to thefirst wall120 and a secondtextured layer137 contained within thecontainer103 adjacent to thesecond wall122. The firsttextured layer136 and the secondtextured layer137 may be constructed from a fluid impermeable material. The firsttextured layer136 and the secondtextured layer137 may each be a sheet of material having a textured side that is corrugated or comprises a plurality of protrusions or projections extending into the chamber of thecontainer103 and facing theabsorptive lamination130. The textured sides of the firsttextured layer136 and the secondtextured layer137 may have other shapes resulting from being channeled, creased, folded, grooved, indented, pleated, or ribbed. When the chamber of thecontainer103 subjected to a reduced pressure, the firsttextured layer136 and the secondtextured layer137 collapse against the sides of theabsorptive lamination130. The firsttextured layer136 and the secondtextured layer137 may provide a fluid reservoir for a bolus of bodily fluid entering thecontainer103, allowing the bodily fluid from thetissue site110 to be distributed more thoroughly across the face of theabsorptive lamination130 to enhance the ability of theabsorptive layers132 collect and store such fluids. Additionally, textured surfaces of the firsttextured layer136 and the secondtextured layer137 provide additional spacing adjacent the outermostabsorptive layers132 and/or the wicking layers134 to further enhance the flow of bodily fluids throughout the entireabsorptive lamination130.
• Theabsorptive layers132 and the wicking layers134 may be organized in other alternating sequences of absorptive material and wicking material. Additionally, theabsorptive layers132 and the wicking layers134 may be formed into a composite rather than being discrete layers of material. For example, an absorptive composite may be formed from co-extruding absorptive material and wicking material such that the absorptive composite possesses characteristics similar to the characteristics of the discreteabsorptive layers132 and the wicking layers134. The absorptive and wicking lamina of the absorptive composite would then be aligned in an alternating sequence when disposed within thecontainer103.
• In operation, theabsorptive lamination130 including wicking layers interleaved between the absorptive layers within thecontainer103 greatly enhances the ability of thecontainer103 to expand and completely fill the chamber as described above, especially when oriented in a generally vertical position. Referring more specifically toFIGS. 2, 2A, and 2B, thecontainer102 of thecanister102 is shown as being substantially vertically oriented and expanding from an empty state to being partially filled and then completely filled, respectively. Referring toFIG. 2A, thecontainer102 is shown as being partially filled with bodily fluids and expanding at the lower end near the bottom of thecontainer102. The bodily fluids and exudates are drawn from thetissue site110 into theinlet104 and thetube127, and then flow into the chamber of thecontainer102 through thedistal end128 of thetube127. When the bodily fluids enter the chamber of thecontainer102, they begin to separate into gaseous and liquid components with the gaseous fluids exiting theoutlet105 as indicated by thearrows129 and the liquid fluids manifolding down the side of theabsorptive lamination130 with the assistance of gravity as indicated byliquid line139. The liquid bodily fluids are manifolded through a combination of the wicking action created by the wicking layers134 and the osmotic pressure of theabsorptive layers132, and supplemented by the effects of gravity which pulls the fluid downward toward the bottom of thecontainer102 which begins to expand along with the expandingabsorptive layers132. This leaves the top of thecontainer102 generally unobstructed by the liquid fluids to manifold the reduced pressure through thetube127 to theoutlet105. This action also facilitates fluid flow by pulling intermittent bolus' of liquid fluids and exudates from thetissue site110 down to the bottom of thecontainer102 by gravity where theabsorbent layers132 have more time to trap and retain the liquid fluids.
• As can be seen in the illustration, theabsorptive layers132 continue to expand as the wicking layers132 continue to channel the liquid fluids across the surfaces of theabsorptive layers132 and the longer theabsorptive layers132 are submersed in the liquid fluids. For example, the most distalabsorptive layer132ahas expanded more at the lower end which has expanded more than the lower end of the most proximalabsorptive layer132bwith varying degrees of absorption and expansion for each interveningabsorptive layer132. As thecontainer102 continues to fill with the liquid fluids, theabsorptive layers132 continue to expand until they reach a full capacity such that thecontainer102 is fully expanded in a filled state as shown inFIG. 2B. When the chamber of thecontainer102 is substantially filled, the liquid fluid eventually covers thedistal end128 of thetube127 as shown byfluid line139′ which substantially prevents the continuing flow of bodily fluids from thetissue site110. Thecontainer102 is capable of expanding with the expansion of theabsorptive lamination132 by means of any of the embodiments described above. It should be understood that thecontainer102 will function in a substantially horizontal position by virtue of the wicking action provided by the wicking layers134 without the aid of gravity as long as thedistal end128 of thetube127 is in an elevated position.
• Referring now toFIG. 3, acontainer303 is shown is substantially similar in all respects to thecontainer103 ofFIGS. 1 and 2 except for the shape as pointed out above. Thecontainer303 also comprises a first wall320 and asecond wall322 joined together by the connectingmember324. As also described above, thecontainer303 may be constructed of a liquid impervious material such as, for example, a thermoplastic such as polyurethane. In one exemplary embodiment, the first wall320 and thesecond wall322 of thecontainer303 may be constructed of polyurethane film having a cross-sectional thickness greater than about 50 μm wherein thecontainer303 is substantially impervious to vapor. In another exemplary embodiment, the first wall320 and asecond wall322 of thecontainer303 may comprise a material permeable to vapor such as, for example, the same polyurethane film wherein the polyurethane film has a cross-sectional thickness less than about 50 μm but greater than about 1582 m. If thecontainer303 is permeable to vapor, the reducedpressure treatment unit101 may further comprise apositive pressure source140 that may provide positive pressure to thecontainer303 to facilitate the evaporation of collected bodily fluid into vapor and the subsequent transmission of vapor through thecontainer303 and into the atmosphere. In one embodiment, the source ofpositive pressure140 may be the exhaust of the sourcenegative pressure108. In another embodiment, thepositive pressure source140 may be activated when thenegative pressure source108 is deactivated.
• In yet another exemplary embodiment, the first wall320 and thesecond wall322 of thecontainer303 may be substantially impervious to vapor but may further comprise portions orregions150 having a cross-sectional thickness greater than about 5 μm and less than about 50 μm that are permeable to vapor. Theregions150 of vapor permeability allow bodily fluid collected in thecontainer303 to evaporate into the atmosphere as described above and further assisted by providing positive pressure to the chamber of thecontainer303. Theregions150 may have varying shapes such as, for example, the shape of a regular polygon or an ellipse. Theregions150 may comprise between about 5% and about 95% of the surface area of thecontainer303.
• In yet another embodiment, a method for collecting bodily fluid from a tissue site is provided. The method comprises disposing a plurality of absorptive layers with wicking layers interleaved between the absorptive layers into a container of a bodily fluid canister, fluidly coupling the container to both a source of bodily fluid and a source of negative pressure, and applying negative pressure through the container to the source of bodily fluid. The method further comprises utilizing the negative pressure to draw the bodily fluids from the tissue site and manifold the bodily fluids to the absorptive layers to collect and trap the liquid portion of the bodily fluids, and allowing the container to volumetrically expand as the absorptive layers swell in size, whereby the container expands to a full state after the absorptive layers are fully absorbed with the liquid fluids.
• It will be appreciated that the illustrative embodiments described herein may be used with reduced pressure treatment systems of any type, shape, or size and similarly with canisters of any type, shape, or size. The location of the inlet, outlet, semi-permeable membrane, and flexible bag may also vary depending upon the particular collection system design. Similarly, the geometry of the semi-permeable membrane may be modified as necessary to conform to the contours or configuration of the canister. Similarly, the location of the means to withdraw the collected absorbent may also vary depending upon the particular collection system design.
• It should be apparent from the foregoing that an invention having significant advantages has been provided. While the invention is shown in only a few of its forms, it is not just limited but is susceptible to various changes and modifications without departing from the spirit thereof.

Claims (19)

We claim:

1. A canister for collecting bodily fluids from a tissue site, comprising:

a first wall,

a second wall, the first wall and the second wall substantially impervious to vapor,

a plurality of absorptive layers,

a plurality of wicking layers positioned proximate the plurality of absorptive layers,

a connecting member positioned about a perimeter of the first wall and the second wall and configured to couple the first wall and the second wall, and

one or more vapor permeable regions disposed in the first wall and the second wall.

2. The canister ofclaim 1, further comprising:

an inlet configured to be in fluid communication with the tissue site;

an outlet configured to be in fluid communication with a reduced pressure source; and

a container including the first wall and the second wall, the container configured to collect fluids from the tissue site.

3. The canister ofclaim 2, wherein the first wall, the second wall, and the connecting member define a chamber.

4. The canister ofclaim 3, wherein the inlet and the outlet are disposed on one of the first wall or the second wall, and wherein the canister further comprises a tube fluidly coupled to the inlet and extending into the chamber away from the outlet.

5. The canister ofclaim 1, wherein the first wall and the second wall are oriented parallel to the absorptive layers and the wicking layers.

6. The canister ofclaim 1, wherein the wicking layers have flow channels for supporting fluid flow across a surface of the absorptive layers.

7. The canister ofclaim 1, further comprising at least one spacer between the wicking layers of the absorptive layers to maintain a space between adjacent wicking layers under reduced pressure.

8. The canister ofclaim 1, wherein the first wall and the second wall are configured to expand as the absorptive layers swell.

9. The canister ofclaim 1, wherein the one or more vapor permeable regions comprise a polygonal shape.

10. The canister ofclaim 1, wherein the one or more vapor permeable regions comprise an elliptical shape.

11. The canister ofclaim 1, wherein the one or more vapor permeable regions comprise between about 5% and about 95% of a surface area of the first wall and the second wall.

12. The canister ofclaim 11, wherein the one or more vapor permeable regions have a cross-sectional thickness less than about 50 μm and greater than about 582 m.

13. The canister ofclaim 1, wherein the first wall and the second wall comprise a thermoplastic material having a cross-sectional thickness greater than about 5082 m.

14. The canister ofclaim 1, wherein the canister further comprises a first textured layer disposed adjacent the first wall.

15. The canister ofclaim 1, wherein the canister further comprises a second textured layer disposed adjacent the second wall.

16. The canister ofclaim 1, wherein the connecting member comprises pleats.

17. The canister ofclaim 1, wherein the connecting member comprises an elastic material.

18. The canister ofclaim 1, further comprising an antimicrobial agent disposed in at least one of the plurality of absorptive layers and the plurality of wicking layers.

19. The canister ofclaim 1, wherein the first wall is adapted to translate away from the second wall.

Images